Vaishali Pharma Ltd - Stock Valuation and Financial Performance

BSE: 0 | NSE: VAISHALI | Pharmaceuticals & Drugs | Small Cap

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Vaishali Pharma

Overall Rating
M-Cap below 500cr. High Risk from low Liquidity Bole Toh

1. Quality

2. Valuation

Undervalued

3. Price Trend

Vaishali Pharma stock performance -

mw4me loader
P/E Ratio (SA):
215.07
Market Cap:
235.1 Cr.
52-wk low:
0
52-wk high:
0

Is Vaishali Pharma Ltd an attractive stock to invest in?

1. Is Vaishali Pharma Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Vaishali Pharma Ltd is a average quality company.

2. Is Vaishali Pharma Ltd undervalued or overvalued?

The key valuation ratios of Vaishali Pharma Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone.

3. Is Vaishali Pharma Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Vaishali Pharma Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Vaishali Pharma:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Vaishali Pharma Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
ROCE % 14%12.8%16.2%12.8%9.8%6.9%10.3%18.9%21.9%5.8%-
Value Creation
Index
0-0.10.2-0.1-0.3-0.5-0.30.40.6-0.6-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 94.666.76467.875.160.153.875.869.786.399
Sales YoY Gr.--29.5%-4.1%5.9%10.8%-20%-10.5%41%-8.1%23.9%-
Adj EPS 0-000.10-0.10.10.40.60.10.1
YoY Gr.--133.3%NA250%-71.4%-350%NA400%68.6%-89.8%-
BVPS (₹) 0.70.70.12222.12.53.13.34.3
Adj Net
Profit
0.2-0.10.70.70.2-0.60.83.76.20.61
Cash Flow from Ops. -3.74.60.5-9.54.33.221.31.10.8-
Debt/CF from Ops. -6.84.649.6-1.945.28.715.812.715.6-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales -1%2.8%17.1%23.9%
Adj EPS 8%24.6%-5%-89.8%
BVPS19.5%10.5%16.2%6.7%
Share Price - -6.3% -17.7% -89.8%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
Return on
Equity %
5.1-1.519.85.61-2.73.515.218.61.42.4
Op. Profit
Mgn %
-0.30.85.44.12.81.54.99.113.51.90.9
Net Profit
Mgn %
0.2-0.11.110.3-11.44.98.90.71.2
Debt to
Equity
7.86.65.80.90.80.80.80.80.40.40
Working Cap
Days
182244255283312396501390400318158
Cash Conv.
Cycle
63104107122115137152122168135100

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 17.07%

Debt to equity has declined versus last 3 years average to 0.35

Sales growth is good in last 4 quarters at 40.61%

Return on Equity has declined versus last 3 years average to 2.40%

Net Profit has been subdued in last 3 years -5.01%

Latest Financials - Vaishali Pharma Ltd.

Standalone Consolidated
TTM EPS (₹) 0.1 -
TTM Sales (₹ Cr.) 99.2 -
BVPS (₹.) 4.3 -
Reserves (₹ Cr.) 29 -
P/BV 4.32 -
PE 215.07 -
From the Market
52 Week Low / High (₹) 0.00 / 0.00
All Time Low / High (₹) - / -
Market Cap (₹ Cr.) 235
Equity (₹ Cr.) 25.6
Face Value (₹) 2
Industry PE 44.3

Management X-Ray of Vaishali Pharma:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Vaishali Pharma

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Sales95676468756054767086
Operating Expenses 95666065735951696085
Manufacturing Costs0000000000
Material Costs91625660695146645574
Employee Cost 2222211111
Other Costs 2333274449
Operating Profit 0133213792
Operating Profit Margin (%) -0.3%0.8%5.4%4.1%2.8%1.5%4.9%9.1%13.5%1.9%
Other Income 4312222222
Interest 3333333222
Depreciation 0000000011
Exceptional Items 0000000000
Profit Before Tax 0011101691
Tax 0001000220
Profit After Tax 0011101471
PAT Margin (%) 0.2%0.0%1.1%1.2%1.0%0.1%1.9%5.3%9.5%0.8%
Adjusted EPS (₹)0.00.00.00.10.10.00.10.40.60.1
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24

Equity and Liabilities

Shareholders Fund 33421212122263336
Share Capital 113771111111111
Reserves 33114151112162225
Minority Interest0000000000
Debt24202118161616201311
Long Term Debt8433544354
Short Term Debt161518151112121778
Trade Payables17251522252441281819
Others Liabilities 124465771513
Total Liabilities 46494564696686817980

Fixed Assets

Gross Block2322233344
Accumulated Depreciation1101112222
Net Fixed Assets2111111122
CWIP 0000000011
Investments 0000000000
Inventories3312111130
Trade Receivables34403745494767595449
Cash Equivalents 1100000112
Others Assets53416161616191826
Total Assets 46494564696686817980

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Cash Flow From Operating Activity -450-9432111
PBT 0011101691
Adjustment 0122263216
Changes in Working Capital -44-3-122-2-3-5-7-4
Tax Paid 00000-10-1-2-2
Cash Flow From Investing Activity 2311000-101
Capex -2000000-100
Net Investments 0000000000
Others 4311000011
Cash Flow From Financing Activity 2-8-18-4-3-20-2-1
Net Proceeds from Shares 00016000000
Net Proceeds from Borrowing 5-42-22-11-22-1
Interest Paid -3-3-3-3-3-3-3-2-2-2
Dividend Paid 0000000000
Others 0-1-1-3-3005-22
Net Cash Flow 0000000101
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Ratios
ROE (%)5.12-0.9419.86.493.40.154.7816.522.262.09
ROCE (%)14.0412.816.1812.759.86.8910.3318.8721.925.82
Asset Turnover Ratio1.911.41.361.251.130.890.710.910.871.09
PAT to CFO Conversion(x)N/AN/A0-94N/A20.250.141
Working Capital Days
Receivable Days140205222221228293386301294218
Inventory Days22181387653107
Payable Days9712313011512517225419815592

Vaishali Pharma Ltd Stock News

Vaishali Pharma Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Vaishali Pharma on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Vaishali Pharma stood at ₹235.1.
The latest P/E ratio of Vaishali Pharma as of 01-Jan-1970 05:30 is 215.1.
The latest P/B ratio of Vaishali Pharma as of 01-Jan-1970 05:30 is 4.32.
The 52-week high of Vaishali Pharma is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Vaishali Pharma is ₹99.16 ( Cr.) .

About Vaishali Pharma Ltd

No data to display
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.